Financials
| Half-year Report | Sep. 09, 2024 |
| Notice of AGM & Annual Report & Accounts | Jun. 05, 2024 |
| Final Results | Jun. 05, 2024 |
| Interim results | Aug. 31, 2023 |
| Final Results | May. 11, 2023 |
| Interim Results or the 6mths Ended 30 June 2022 | Sep. 30, 2022 |
| Notice of AGM & Annual Report & Accounts | Jun. 01, 2022 |
Proxies
| Result of AGM | Jun. 28, 2024 |
| Result of AGM | Jun. 30, 2023 |
| IMM RNS Posting of RA and Notice of AGM 30 June 23 | Jun. 06, 2023 |
| Result of AGM | Jun. 28, 2022 |
| 2021 RESULT OF ANNUAL GENERAL MEETING -REPLACEMENT | Jun. 28, 2021 |
| 2021 RESULT OF ANNUAL GENERAL MEETING | Jun. 28, 2021 |
| 2020 AGM – ALL RESOLUTIONS PASSED | Jun. 18, 2020 |
Ownership Update
| Holding(s) in Company | Dec. 10, 2024 |
| Holding(s) in Company | Aug. 06, 2024 |
| Holding(s) in Company | May. 03, 2024 |
| Grant of Share Options | Apr. 19, 2024 |
| Grant of Share Options | Mar. 19, 2024 |
| Holding(s) in Company | Dec. 28, 2023 |
| Holding(s) in Company | Dec. 19, 2023 |
Announcements
| Breakthrough Findings into Autoimmune Diseases | Jan. 09, 2025 |
| IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE | Jan. 08, 2025 |
| Change of Auditor | Dec. 23, 2024 |
| Appointment of Company Secretary | Dec. 04, 2024 |
| Extension of Warrants in Incanthera to 31 Mar 2025 | Sep. 09, 2024 |
| Realisation-c£1.5m on sale of shares in Incanthera | Jun. 03, 2024 |
| IMMUPHARMA AT BIO-EQUITY 2024 12-14 May | Apr. 24, 2024 |